Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,000 | 47,700 | 23,500 | 61,600 | 17,900 |
| Receivables | 109,300 | 100,600 | 119,000 | 116,400 | 136,200 |
| Inventories | 86,100 | 86,600 | 80,700 | 77,200 | 88,400 |
| Income taxes - deferred | 18,000 | 18,200 | 25,900 | 22,000 | 24,800 |
| Other current assets | 0 | 20,000 | 0 | 0 | 0 |
| TOTAL | $287,000 | $292,000 | $274,900 | $316,200 | $306,400 |
| Non-Current Assets | |||||
| PPE Net | 177,400 | 187,800 | 176,700 | 173,500 | 185,400 |
| Investments And Advances | 93,500 | 92,900 | 89,500 | 95,200 | 94,400 |
| Intangibles | 401,400 | 402,400 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,100 | 7,800 | 418,500 | 422,300 | 516,700 |
| TOTAL | $678,400 | $690,900 | $684,700 | $691,000 | $796,500 |
| Total Assets | $965,400 | $982,900 | $959,600 | $1,007,200 | $1,102,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,500 | 1,100 | 200 | 49,200 | 61,500 |
| Accounts payable and accrued liabilities | 166,300 | 183,500 | 157,200 | 149,900 | 167,400 |
| TOTAL | $167,800 | $184,600 | $157,400 | $199,100 | $228,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 290,800 | 309,800 | 339,100 | 339,000 | 352,900 |
| Other Non-Current Liabilities | 20,500 | 29,800 | 50,500 | 53,400 | 57,100 |
| TOTAL | $311,300 | $339,600 | $389,600 | $392,400 | $410,000 |
| Total Liabilities | $479,100 | $524,200 | $547,000 | $591,500 | $638,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 714,841 | 712,856 | 710,459 | 707,581 | 705,987 |
| Common Shares | 59,500 | 59,300 | 59,200 | 58,900 | 58,800 |
| Retained earnings | 108,500 | 87,700 | 70,600 | 56,100 | 111,800 |
| Other shareholders' equity | 30,700 | 25,500 | -1,800 | 19,400 | 14,400 |
| TOTAL | $486,300 | $458,700 | $412,600 | $415,700 | $464,000 |
| Total Liabilities And Equity | $965,400 | $982,900 | $959,600 | $1,007,200 | $1,102,900 |